Wolfe Research Initiates Biogen(BIIB.US) With Hold Rating
Raymond James Maintains Biogen(BIIB.US) With Hold Rating
Biogen Initiated at Neutral by Citigroup
Biogen Analyst Ratings
Citi Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $190
Argus Cuts Biogen's Price Target to $200 From $250
J.P. Morgan Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $210
Biogen Analyst Ratings
JP Morgan Maintains Neutral on Biogen, Lowers Price Target to $210
A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $190 to $302
Biogen Price Target Cut to $180.00/Share From $190.00 by Barclays
Biogen Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Biogen, Lowers Price Target to $275
Redburn Atlantic Adjusts Price Target on Biogen to $190 From $230
Biogen Analyst Ratings
A Quick Look at Today's Ratings for Biogen(BIIB.US), With a Forecast Between $190 to $315
Biogen Price Target Maintained With a $270.00/Share by Needham
Morgan Stanley Downgrades Biogen to Equal-Weight, Lowers Price Target to $204
Needham Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $270
Needham Reiterates Buy on Biogen, Maintains $270 Price Target